Inventor

LEDBETTER JEFFREY A

US80 patents

⚠️ This page may combine multiple inventors who share the name “LEDBETTER JEFFREY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEDBETTER JEFFREY A

BRISTOL MYERS SQUIBB CO

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

CTLA4/CD28Ig hybrid fusion proteins and uses thereof

CTLA4 receptor and uses thereof

CTLA4 receptor and uses thereof

CTLA4 receptor and uses thereof

CTLA4 receptor and uses thereof

Soluble CTLA4 molecules and uses thereof

CTLA4 Ig fusion proteins

MYPPPY variants of CTL A4 and uses thereof

Anti-GP39 antibodies

B7Ig fusion protein

CD28IG fusion protein

Chimeric CTLA4 receptor and methods for its use

Method of regulating cellular processes mediated by B7 and CD28

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith

Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules

Mixed specificity fusion proteins

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions

Method to inhibit T cell interactions with soluble B7

Soluble and its use in B cell stimulation

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

Inhibiting B cell activation with soluble CD40 or fusion proteins thereof

Soluble CTLA4 mutant molecules and uses thereof

Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigen

Monoclonal antibodies and FV specific for CD2 antigen

Monoclonal antibodies and FV specific for CD2 antigen

Methods for blocking binding of CD28 receptor to B7

Method for generating and identifying antibodies directed against a B7

XOMA CORP

Chimeric antibody with specificity to human B cell surface antigen

Chimeric antibody with specificity to human B cell surface antigen

Chimeric antibody with specificity to human B cell surface antigen

LEDBETTER JEFFREY A

Therapeutic nuclease compositions and methods

Ligands and methods for augmenting B-cell proliferation

Binding domain-immunoglobulin fusion proteins

TRUBION PHARMACEUTICALS INC

Binding domain-immunoglobulin fusion proteins

DNA vaccines encoding antigen linked to a domain that binds CD40

Binding constructs and methods for use thereof

ROYALTY PHARMA FINANCE TRUST

Chimeric antibody with specificity to human B cell surface antigen

Chimeric antibody with specificity to human B cell surface antigen

DARTMOUTH COLLEGE

Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells

Methods of inducing T cell non-responsiveness to transplanted tissues and of treating graft-versus-host-disease with anti-gp39 antibodies

BRISTOL MEYERS SQUIBB CO

Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity

PHARMACEUTICAL ROYALTIES L L C

Chimeric antibody with specificity to human B cell surface antigen

ONCOGEN

Bp 50-specific antibodies and fragments thereof

GENETIC SYSTEMS CORP

T-cell lymphocyte subset monitoring of immunologic disease

THOMPSON PETER ARMSTRONG

Single chain multivalent binding proteins with effector function

TRUBION PHARMACEUTICALS

Binding constructs and methods for use thereof

UNIV WASHINGTON

Therapeutic nuclease compositions and methods